EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Regulation of immune responses by pharmacological modulation of major histocompatibility complex (MHC)-restricted antigen presentation

Sang-Hyun Kim, Chong-Kil Lee

MedPharmRes · 31.03.2026 · 10 (1) · 1-9

DOI: 10.32895/mpr.26.00007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift MedPharmRes, online erschienen am 31.03.2026. Verfasst von Sang-Hyun Kim und 1 weiteren Autor:innen. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Major histocompatibility complex (MHC)-restricted antigen presentation is a fundamental process that initiates and shapes T cell-mediated immune responses. While most current immunomodulatory therapies target downstream signaling pathways of T cell activation, growing evidence highlights antigen presentation as a critical upstream determinant of T cell specificity, magnitude, and functional outcome. Pharmacological agents that modulate antigen processing, peptide loading, and MHC surface expression can profoundly alter T cell priming and immune responses. In this review, we briefly summarize the molecular mechanisms governing MHC class I- and class II-restricted antigen presentation, including cross-presentation by professional antigen-presenting cells. We then discuss emerging pharmacological modulators that regulate T cell responses by targeting MHC-restricted antigen presentation pathways, including calcineurin inhibitors, proteasome and immunoproteasome inhibitors, epigenetic regulators, endoplasmic reticulum stress modulators, and autophagy-targeting agents. By highlighting how these agents influence antigen processing and presentation independently of direct T cell signaling, we propose pharmacological modulation of MHC-restricted antigen presentation as an underexplored yet powerful strategy for immune intervention.

Zitieren

APA

Kim, S., & Lee, C. (2026). Regulation of immune responses by pharmacological modulation of major histocompatibility complex (MHC)-restricted antigen presentation. MedPharmRes, 10(1), 1-9. https://doi.org/10.32895/mpr.26.00007

Vancouver

Kim S, Lee C. Regulation of immune responses by pharmacological modulation of major histocompatibility complex (MHC)-restricted antigen presentation. MedPharmRes. 2026;10(1):1-9. doi:10.32895/mpr.26.00007

BibTeX
@article{Kim2026,
  author = {Kim, Sang-Hyun and Lee, Chong-Kil},
  title = {Regulation of immune responses by pharmacological modulation of major histocompatibility complex (MHC)-restricted antigen presentation},
  journal = {MedPharmRes},
  year = {2026},
  volume = {10},
  number = {1},
  pages = {1--9},
  doi = {10.32895/mpr.26.00007}
}
Kostenlos starten →